Logo

OpiCalc

FavoritesSpecialtiesDrugsGuidelinesMost Used

Quick Access

Favorites
Most Used

All Specialties

OpiCalc Logo
Clinical CalculatorsDrugsGuidelines
SpecsDrugsGuides
AKI Staging (KDIGO)Anion Gap + Delta-DeltaCKD Stage (KDIGO)Creatinine ClearanceElectrolyte & Free WaterFENaFEUreaKFRE — Kidney Failure RiskKt/V DialysisSodium CorrectionUACRUPCRUrea Reduction Ratio (URR) CalculatorUric Acid & FEUAUrinary Anion GapWinter's FormulaeGFR (CKD-EPI)
OpiCalc Logo

OpiCalc

Easy, fast, and private medical tools for clinicians. Always free.

No Login Required
Ready for the Bedside

Resources

About UsEditorial PolicyMedical DisclaimerPrivacy PolicyTerms of UseCookie Policy

Support

Contact Us

Clinical Notice:OpiCalc is not a substitute for professional clinical judgment. Always verify dosages and guidelines.

OpiCalc © 2026

•

All Rights Reserved

Creatinine Clearance

Creatinine Clearance Calculator

Cockcroft-Gault Equation

Cockcroft-Gault remains the standard for drug dosing.

Drug Clearance Engine

Enter metrics to execute Cockcroft-Gault dosing verification.

Guidelines & Evidence

Verified

Last Review: 2026-07-17

When to Use

Core Clinical Uses

Primary method for renal drug dosing adjustment (FDA labeling standard).
Estimation of kidney function in stable adult patients using serum creatinine.
Baseline renal function assessment prior to initiating nephrotoxic medications.
Monitoring renal function trends in chronic kidney disease (CKD).
Dose individualisation for narrow therapeutic index drugs (e.g., aminoglycosides, vancomycin, lithium, digoxin).

High-Impact Clinical Scenarios

Sepsis and ICU patients receiving renally cleared antibiotics.
HIV/TB patients on tenofovir, aminoglycosides, or amphotericin B.
Elderly patients with polypharmacy and reduced muscle mass.
Oncology patients receiving nephrotoxic chemotherapy.

When NOT to Use

Avoid use in acute kidney injury (AKI) or rapidly changing creatinine levels. Not validated in children, pregnancy, or patients with extreme body composition (e.g., amputees, severe obesity) without appropriate adjustments. In ICU patients, may significantly misrepresent true GFR.

How it Works

Cockcroft-Gault Equation

CrCl (Male) = [(140 − Age) × Weight (kg)] / [72 × Serum Creatinine (mg/dL)] CrCl (Female) = CrCl × 0.85

Physiological Basis

Creatinine is generated from muscle metabolism at a relatively constant rate. The formula estimates creatinine production using age, sex, and body weight as proxies for muscle mass. Clearance is then inferred by dividing estimated production by serum creatinine concentration.

Key Assumptions

Steady-state creatinine production and excretion.
Stable renal function over preceding 24–48 hours.
Normal relationship between muscle mass and total body weight.

Comparison with Other GFR Estimators

Cockcroft-GaultDrug dosing standard; influenced by weight.
CKD-EPIMost accurate for GFR estimation; preferred for CKD staging.
MDRDLess accurate at higher GFR (>60 mL/min).
24-hour Creatinine ClearanceGold standard but impractical and error-prone.

Clinical Pearls

Weight Selection (Critical for Accuracy)

Underweight or normal BMI: Use Actual Body Weight (ABW).
Obese (BMI > 30): Use Adjusted Body Weight (AjBW = IBW + 0.4 × [TBW − IBW]).
Morbid obesity: Consider capping weight or using alternative methods (e.g., CKD-EPI).

Interpretation Bands

≥ 90 mL/minNormal renal function
60–89 mL/minMild impairment
30–59 mL/minModerate impairment
15–29 mL/minSevere impairment
< 15 mL/minKidney failure (consider dialysis)

Major Pitfalls

Overestimation of GFR due to tubular secretion of creatinine.
Low muscle mass (elderly, cachexia, liver disease) → falsely elevated CrCl.
High muscle mass (bodybuilders) → underestimated renal impairment.
Recent cooked meat ingestion → transient creatinine elevation.
Fluid overload or dehydration distorting serum creatinine concentration.

Advanced Clinical Pearl

In critically ill or septic patients, Cockcroft-Gault may significantly overestimate renal function. Consider using dynamic markers (e.g., urine output trends, cystatin C if available) and dose conservatively.

Next Steps

Drug Dosing Strategy

01
Match CrCl to drug-specific dosing thresholds (check label or guidelines).
02
Adjust dosing interval (e.g., 12-hourly → 24-hourly) or reduce dose.
03
Avoid nephrotoxic drugs where possible (NSAIDs, aminoglycosides, contrast).
04
Use therapeutic drug monitoring (TDM) for high-risk drugs.
05
Reassess renal function frequently in unstable patients.

Common Drug Adjustments

AminoglycosidesExtend dosing interval (extended-interval dosing preferred).
VancomycinDose based on trough levels and CrCl.
TenofovirReduce frequency if CrCl < 50 mL/min.
MetforminAvoid if CrCl < 30 mL/min (risk of lactic acidosis).

Diagnostic Follow-up

01
If CrCl < 60 mL/min for > 3 months → evaluate for CKD.
02
Order urine ACR and urinalysis.
03
Assess for reversible causes (dehydration, obstruction, drugs).
04
Refer to nephrology if CrCl < 30 mL/min or rapid decline.

The Evidence

Foundational Study

Prediction of creatinine clearance from serum creatinine.

Cockcroft DW et al. • Nephron. 1976;Derived from 249 adult patients; established bedside estimation method.

Guideline Context

Although CKD-EPI is recommended for CKD staging (KDIGO), Cockcroft-Gault remains the regulatory standard for drug dosing decisions in most pharmaceutical labeling.

Origins & History

Historical Development

Developed in 1976 in Montreal, Canada, the Cockcroft-Gault equation provided a rapid bedside alternative to 24-hour urine collection, revolutionizing drug dosing safety.

Clinical Impact

This equation enabled real-time dose adjustment, significantly reducing drug toxicity, especially with the expansion of antibiotics and chronic disease therapies.

Last Comprehensive Review: 2026-07-17

In Recent Clinical News

Scanning Medical Journals

No new significant updates or guidelines matching this topic were found today. We will check again soon.